Johnson & Johnson vs. Protagonist Therapeutics, Inc
Johnson & Johnson and Protagonist Therapeutics, Inc are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | PTGX | |
|---|---|---|
| Market Cap | $675.03 billion | $8.87 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | PTGX | |
|---|---|---|
| Dividend Yield | 1.89% | — |
JNJ and PTGX split the dividend factors evenly.
Risk & Sentiment
| JNJ | PTGX | |
|---|---|---|
| Short Interest | 0.67% | 0.62% |
PTGX leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, PTGX overview, PTGX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.